Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Shahriare Mahmood joins Spinnova's Management Team

Sustainable textile material company Spinnova has appointed Shahriare Mahmood as Chief Sustainability Officer and member of the management team.As Chief Sustainability Officer, Shahriare Mahmood will be responsible for Spinnova’s sustainability and textile development, reporting to the Chief Executive Officer. Both textile development and ensuring sustainable supply chains are Mahmood’s area of expertise. As part of its strategy, Spinnova is developing both fibre and its own fabric made of the SPINNOVA® fibre, as well as applications with brand partners. The first commercial factory

Sleep Cycle interim report January-June 2021:  Continued growth coupled with increased investments in marketing, headcount and stock exchange listing

During the second quarter the number of subscribers continued to grow to a total of 852k, an increase of 14.5%. Net revenues increased by 12.5%, corresponding to 20.3% adjusted currency. Growth was driven by high renewal rates, effective investment in marketing and new growth initiatives such as B2B sales and partnership programs. Increased spend on marketing, a growing organization and the stock exchange listing contributed to a planned increase in costs and therefore a decline in net income for this quarter.Second quarter summary (April-June 2021) · Net sales increased by 12.5 (37.1)

Implantica appoints new experienced team to lead commercial operations

Implantica AG (publ) today announces that a new team will be heading up the commercial operations at the Company including four highly experienced sales and marketing professionals, two of whom are joining in August 2021. Stefan Vogt is joining as Chief Commercial Officer, having extensive experience in building large sales organisations. Steffen Schanz is joining as VP Marketing and Product Management, with his substantial implant marketing experience. Gerhard Landwehr has been appointed VP Business Development DACH and UK, with over 10 years’ experience in leading positions commercialising

Sedana Medical receives approval in France

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has received market approval for inhaled sedation in France.The approval applies to the drug Sedaconda (isoflurane)* for administration via the medical device AnaConDa (undergoing name change to Sedaconda ACD) for inhaled sedation in intensive care in France. The application has been approved by the French Medicines Agency, L'Agence nationale de sécurité du médicament et des produits de santé (ANSM) and is based on the DCP approval Sedana Medical received in July. “The approval has gone faster than we

Notice of Annual General Meeting in Sectra AB (publ)

The shareholders of the medical imaging IT and cyber security company Sectra AB (publ) are hereby invited to the Annual General Meeting held on Tuesday, September 14, 2021.Extraordinary measures due to the covid-19 pandemicSectra is keen to safeguard the wellbeing of the shareholders and seeks to contribute to the efforts to reduce the spread of the corona virus. The Board of Directors of Sectra has therefore decided that the Annual General Meeting (“AGM”) shall be conducted without the physical presence of shareholders, proxy holders and guests and that the shareholders shall be able to

Bio-Works confirms two new orders from contract manufacturer Catalent Biologics

Bio-Works Technologies AB has confirmed that they have received two new orders from contract manufacturer Catalent Biologics for a total order value of 778 KSEK (94,512 USD). The orders are expected to ship in the second half of this year. “We are proud that Catalent Biologics has chosen Bio-Works to supply chromatography resins for this project. Catalent Biologics is a fast-growing, global contract manufacturer with innovative technologies and integrated solutions that are leveraged by companies ranging from small biotech to large biopharma. Their deep expertise and patient first

Invitation to LeadDesk’s January–June 2021 results briefing

LeadDesk Plc Press Release 13 August 2021 8.05 CETLeadDesk will publish their 1.1.-30.6.2021 financial statements bulletin on Friday, 27 August 2021 at 8.00 CET (at 9.00 Finnish time). The company is organising a results briefing for analysts, the media and investors on 27 February 2021 at 9.00 CET (at 10.00 Finnish time). The briefing will be held as a Microsoft Teams webcast.LeadDesk CEO Olli Nokso-Koivisto will host the briefing and present the financial statement as well as forecasts for the second half of the year 2021. The event will be held in English. LeadDesk kindly asks

MPC Container Ships ASA announces date for Q2 and six-month 2021 results

Oslo, 13 August 2021 - MPC Container Ships ASA (the "Company") will be releasing its second quarter 2021 report prior to market opening on Thursday 19 August 2021. The Company will host a webcast for the presentation of the Q2 2021 results commencing on Thursday 19 August 2021 at 15:00 hours CEST / 09:00 hours EDT. The presentation will be made available on the Company’s webpage from 12:00 hours CEST / 06:00 hours EDT. There will be a Q&A session after the presentation. The event is being streamed. It is recommended that you listen

First Camp Group Interim report Q2 2021

First Camp, Scandinavia’s largest campsite chain, increased revenues in the second quarter of 2021 by 23% vs same period in 2020, excluding effects from acquisitions (pro forma).Highlights for second quarter 2021 (same quarter last year in brackets) · Total revenue of SEK 101.8 million (81.7) · Pro forma revenue increased with 23% compared to Q2 2020 · EBITDA of SEK 12.4 million (7.4) · Pro forma Adjusted EBITDA amounted to SEK 8.5 million (6.1) · Cash flow from operating activities of SEK 63.7 million (45.3) Highlights for the first two quarters 2021 (same period last

TR-1: notification of major holdings

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN BMG4209G2077 Issuer Name GULF KEYSTONE PETROLEUM LIMITED UK or Non-UK Issuer Non-UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name BlackRock, Inc. City of registered office (if applicable) Wilmington Country of registered office (if applicable) USA 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification

Kamux saw very strong growth, revenue +52.0% - Adjusted operating profit (EBIT) at previous year’s level

Kamux Corporation                Half Year Financial Report                           August 13, 2021 at 09:00 Kamux Corporation’s Half Year Financial Report for January 1 - June 30, 2021 Kamux saw very strong growth, revenue +52.0% - Adjusted operating profit (EBIT) at previous year’s level The figures in parentheses refer to the comparison period, i.e. the same period in the previous year, unless stated otherwise. April-June in brief · Revenue increased by 52.0%, totaling EUR 228.8 million (150.5) · Gross profit decreased by -0.5% to EUR 20.5 million (20.6), or 9.0% (

Navamedic ASA: Q2 and first half 2021 financial results

Oslo, 13 August 2021 – Navamedic ASA (OSE: NAVA) grew revenues by 56.7% in the second quarter of 2021 compared to the same quarter last year. The company reported revenues of NOK 66.0 million in the second quarter of 2021 with an EBITDA of NOK 4.3 million, driven by both new products, underlying growth and an improved revenue mix. The company reiterates its mid- to long-term ambition of building a NOK 500 million company.“We continue to deliver rapid growth for our specialty pharma product Mysimba and consumer health products Alflorex and ThermaCare. In parallel, we expand our product

Change of name and short name (ticker) for shares in CELLINK AB (publ)

The name for the share on Nasdaq Stockholm will be changed from CELLINK AB (publ)  to BICO Group AB (publ). The shares' short name (ticker) will change from CLNK to BICO. The company’s ISIN code and order book ID will be unchanged. The last day for trading in the share's current ticker will be Friday August 13, 2021. The first day for trading in the share's new ticker will be on Monday August 16, 2021. This is an administrative matter and shareholders do not need to take any action. For more information, please contact:Isabelle Ljunggren, Head of Communications   Phone:

Nordic Mining ASA (EN Expand:NOM) - Interim report per 30 June 2021

Please find enclosed Nordic Mining’s interim report and company presentation for the second quarter of 2021. The interim report and company updates will be presented digitally today, Friday 13 August 2021 at 10.00 (CET). The presentation and Q&A session will be held in English and transferred via webcast. You will have the opportunity to post questions online throughout the webcast session. The webcast will be available on: https://channel.royalcast.com/landingpage/hegnarmedia/20210813_5/ Important events in the second quarter of 2021 and year to date: CORPORATE Successful capital

Remedy drives growth with moves towards publishing and new games

Remedy Entertainment Plc | Company announcement 09:00 am (EEST) 13 August 2021 HALF-YEAR REVIEW 1 January – 30 June 2021 (unaudited)  Remedy drives growth with moves towards publishing and new games  Strong financial position, new co-publishing and development agreement signed to expand Control. HIGHLIGHTS FROM APRIL–JUNE 2021 · Revenue 9 417 (9 125) thousand euros, change +3.2 %. · Operating profit (EBIT) 2 304 (2 086) thousand euros, 24.5 % (22.9 %) of revenue. · Remedy signed a co-publishing and development agreement with 505 Games for a multiplayer spin-off game of

Transcom Holding AB (publ): Invitation to Transcom second quarter 2021 results presentation webcast

Transcom are pleased to invite you to their Q2 2021 financial update webcast (live) on Friday, August 27, at 9:00 am CET, following the release of Q2 2021 results at 8:00 am CET. The Q2 report and presentation will be available on https://www.transcom.com/en/investor-relations. Representing Transcom Jonas Dahlberg, President & CEO Snejana Koleva, CFO Presentation details Date/Time: Friday, August 27, 2021 at 9:00 CET Online Registration link: https://app.livestorm.co/transcom-holding/transcom-holding-ab-q2-2021-investor-presentation?type=detailed   Important note:

SimCorp A/S – New Share buyback program

Company Announcement no. 36/2021SimCorp A/S (“SimCorp”) has today initiated a new share buyback program for up to EUR 20.0m, to be executed during the period from 13 August 2021 to 17 December 2021. The buyback program is being launched in accordance with the authorization granted by the shareholders at the Annual General Meeting on 24 March 2020 to repurchase up to 10% of the SimCorp’s share capital in the period until the next annual general meeting. The buyback program will be structured and carried out in compliance with the provisions of Regulation No. 596/2014 of the European

SimCorp reports revenue growth of 9.1% and EBIT margin of 23.6% in H1 2021

Company Announcement no. 35 / 2021Q2 2021 highlights: · Reported revenue was EUR 118.8m, an increase of 11.3% when compared with Q2 2020. Measured in local currencies, organic revenue increased by 12.7% when compared with Q2 2020. · EBIT was EUR 30.0m and EBIT margin was 25.2% compared with EBIT of EUR 26.0m and EBIT margin of 24.4% in Q2 2020. · In Q2 2021, three new SimCorp Dimension orders and one new SimCorp Coric order were signed. · Order intake was EUR 30.2m, an increase of EUR 13.3m or 78.7% compared with Q2 2020. H1 2021 highlights: · Reported revenue was EUR

Christian Kromann appointed Chief Executive Officer of SimCorp

Company Announcement no. 34/2021 – Inside informationSimCorp announces today that Christian Kromann will succeed Klaus Holse as Chief Executive Officer, effective September 2, 2021. Christian has served as SimCorp Chief Operating Officer and member of the Executive Management Board since August 2019.  Chairman of the Board of Directors Peter Schütze comments, "We are delighted to appoint Christian as our Chief Executive Officer. The Board has followed Christian’s performance as COO for the past two years and we are pleased to have a strong and competent internal successor to take over

EQT Private Equity sells Utimaco, a global leader in cybersecurity solutions

· EQT Private Equity to sell Utimaco, one of the global leading providers of mission-critical professional cybersecurity and data intelligence solutions for regulated critical infrastructures · Together with EQT, Utimaco has executed an impressive innovation, growth and M&A strategy, including five add-ons in the US, UK, Spain, and Germany and transformed into one of the leading integrated European cybersecurity champions with global reach · Under EQT’s ownership, Utimaco has close to tripled its revenues and is expected to generate more than EUR 100 million for the fiscal year of

Kesko’s sales grew in July

Kesko Group's sales totalled €954.6 million in July 2021, representing an increase of 8.3% on the previous year. In comparable terms, sales grew by 6.2%.“Kesko’s sales grew by 6.2% in comparable terms in July. Sales for the grocery trade division grew by 4.5%. Sales for the building and technical trade division grew by 8.7% in comparable terms, thanks to strong performance in B2B trade. In the car trade division, sales were up by 6.2% and our market share strengthened,” says Kesko’s President and CEO Mikko Helander. Sales for the grocery trade division totalled €514.9 million in July, an

Aker Carbon Capture Raises NOK 840 Million to Fund Accelerated Growth

Aker Carbon Capture has completed a capital increase of NOK 840 million to support the further growth of its market-leading carbon capture offering.The company issued 38,181,818 new shares in a private placement, priced at NOK 22 per share. The placement was multiple times over-subscribed amidst strong demand, particularly from international investors. “The positive response from investors enabled an effective process to strengthen Aker Carbon Capture’s financial capacity and flexibility to realize our growth ambitions,” said Valborg Lundegaard, Chief Executive Officer of Aker Carbon

Heimstaden AB: Q2 2021 Results

Highlights · SEK 4.6 billion in profit. · Investment properties of SEK 187 billion and 116,679 homes. · Strong operational performance with 97.6% real economic occupancy. · Robust balance sheet with LTV of 41.2% (Q1: 43.3%) and ICR of 3.1x (Q1: 3.0x). · Raised SEK 1.13 billion in issuance of new preference shares on Nasdaq First North Growth. · Heimstaden Bostad entered the United Kingdom with the acquisition of newbuild portfolio in Birmingham. Commenting on the results, CEO Patrik Hall said: “Thanks to our professional and ambitious people, Heimstaden delivered

Heimstaden Bostad: Q2 2021 Results

Highlights · SEK 4.6 billion in profit. · Investment properties of SEK 186 billion and 116,083 homes. · Strong operational performance with 97.6% real economic occupancy. · Robust balance sheet with LTV of 39.6% (Q1: 41.1%) and ICR of 3.5x (Q1: 3.2x). · Issued SEK 3.0 billion in new senior unsecured bonds and a SEK 6.0 billion hybrid bond. · Entered the UK with the acquisition of newbuild portfolio in Birmingham. Commenting on the results, CEO Patrik Hall said: “Thanks to our professional and ambitious people, Heimstaden Bostad delivered strong financial and

There are no items matching the current filter
There are no more items matching the current filter
Back to top